Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCREDIBLE-ME: Metformin and gut-derived incretin hormones in adults with type 1 diabetes mellitus
2018-003022-89Phase 3Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of metformin in diabetes mellitus type 1 (T1D), sponsored by Hellenic Institute for the Study of Sepsis. Primary endpoints: Postprandial GLP-1 and GIP secretion following a mixed meal and Fasting GLP-1 and GIP secretion. Started Oct 2019; status: completed.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2018-003022-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003022-89.